All manuscripts must comply with JIMM editorial policies. The JIMM accepts manuscripts in English related to military medicine. This includes but is not necessarily limited to health issues of armed forces, physiology, trauma and battle injuries, military psychiatry/psychology, emergency medicine, CBRN  medicine, medical administration including mass casualty readiness and response, occupational and environmental medicine (climate-related injuries and tolerance, altitude and diving medicine), as well as training and exercise physiology.

Submissions must include:

1. The main manuscript should be submitted as a single MS WORD document with tables and figures embedded after the references.
    
2. A Cover letter to the editor, including a sentence on the type of manuscript and its content, and its contribution to military medicine. For manuscripts with more than six co-authors, the individual contributions of each author must be detailed.
    
3. The JIMM Submission Form must be signed by all authors regarding copyright transmittal, disclosure of potential conflicts of interest, and other relevant disclosures.
    
4. A copy of IRB approval or Animal Welfare and Ethical Review Body, as relevant. If the study was performed in the IDF, a copy of the IDF IRB approval must be submitted.
    

Manuscript should be submitted to [email protected].

Manuscripts may be of the following types:

1. Report on original research
2. Original clinical observations accompanied by analysis and discussion
3. Letter to the Editor
4. Critical review
5. Case report with discussion
6. Conference summary
7. Clinical guideline/opinion article

Report on original research
An original research article details the results of a study not previously published. To ensure international visibility and facilitate indexing in global databases, the JIMM accepts submissions in English only. All submissions must include a structured abstract (no more than 250 words) with background, methods, results, and conclusions. The article (sectioned: introduction, methods, results, discussion) may be no more than 4,000 words (not including abstract, references, tables, and figures). Up to 20 references are permitted. A total of four tables and figures is allowed. Up to six authors are permitted, but in exceptional cases, the editor may allow more, based on the contribution of all authors as detailed in the cover letter.
 

Original clinical observations accompanied by analysis and discussion (case series)
This category includes prospective or retrospective case series accompanied by analysis and clinical discussion. Its structure and other requirements are identical to the original research article as stated above.

Letter to the Editor
A letter to the Editor is a communication to the editor, usually, but not necessarily, related to an article previously published in the JIMM. Up to two authors are permitted, and a maximum of 750 words is allowed. It has no abstract, tables, or figures, and may include up to three references.
 

Critical review
A critical review article summarizes the data available on a specific topic. The JIMM accepts review submissions in English only to ensure international visibility. All reviews must include a non-structured abstract in English (150–250 words).

The main article is up to 4,000 words, structured as relevant, and up to 40 references. A total of four tables and figures is permitted. Up to three authors are allowed.
 

Case report with discussion
A case report details the history, clinical presentation, workup, and outcome of a patient or disease relevant to the JIMM, followed by a discussion of the findings. Up to three authors are permitted. To ensure international accessibility, submissions are accepted in English only. Each case report must include a non-structured abstract (150–250 words). It is up to 1,500 words and may include up to five references. A total of three tables and figures is permitted. If the case report is based on an image, it may appear under the JIMMAGE category.
 

Conference summary
A conference summary details any aspect of a relevant conference that the author participated in. Up to two authors are permitted, and a maximum of 2,000 words is allowed. This submission type includes no abstract, may feature one table or figure, and may include up to 10 references.

Clinical guideline / Opinion article
A clinical guideline details the approach to the management of a clinical condition or an opinion on a contemporary issue related to military medicine.  Up to three authors are permitted, and the text is limited to 4,000 words. This submission type includes no abstract and may consist of up to four tables, graphs, or figures, and up to 30 references.

Preparing your manuscript
 Use Times New Roman for English (both 12-point). The title page, abstract, tables, and figures must each be presented on separate pages. The main body of the text should remain continuous without internal page breaks. Both pages and lines must be numbered, with continuous line numbering enabled throughout the document.

• References: List references numerically in the order in which they first appear in the text. Cite them in the text using superscript Arabic numerals. References should follow the Vancouver style (NLM standard).
   
•  Abbreviations: Use only standard abbreviations; use of nonstandard abbreviations can be confusing to readers. Avoid abbreviations in the manuscript title. The spelled-out abbreviation followed by the abbreviation in parentheses should be used on first mention unless the abbreviation is a standard unit of measurement.
   
• Units: Please use SI units.
   
• Language: Manuscripts must be submitted in English. The level of the general and scientific English must be appropriate for the JIMM;  manuscripts that do not meet these standards will be returned to the authors for professional copyediting. Submissions translated via automated tools (e.g., Google Translate) or unrefined AI outputs are not acceptable and will be returned for professional language revision before being considered for review.
   
• Medications: Always present generic names. If a proprietary (brand) name is particularly relevant to the study, it should be included in brackets, followed by the manufacturer’s name, city, and state/country.
   
• Tables: Tables should be numbered and cited in the text in sequence using Arabic numerals (i.e., Table 1, Table 2, etc.). Tables may not exceed one A4 page in length and should be placed at the end of the document text file. Color and shading may be used, but markings should be sufficient to differentiate the various aspects, even when printed in black and white. Parts of the table can be highlighted using superscript, numbering, lettering, symbols, or bold text; all of which must be explained in a table legend. Commas should not be used to indicate numerical values.
   
• Figures: Figures should be numbered and cited in the text in sequence using Arabic numerals (i.e., Figure 1, Figure 2, etc.). Fig Figures should be closely cropped to minimize white space surrounding the illustration; this ensures הבנתי שיהיה לaccuracy during the final layout process. Individual figure files must not exceed 10 MB.
  Embed tables and figures at the end of the manuscript (after the references), each on a separate page. Each table and figure must include a clear legend: a concise title (max 15 words) on the first line, followed by a detailed description (max 30 words) on a separate line to ensure the data can be understood independently. Do not include legend text within graphic files. Tables should not exceed one A4 page, and commas must not be used to indicate numerical values. Finally, indicate the preferred placement within the main text using a separate line, such as
  <Please place Table 1 here> 
  <Please place Figure 3 here>

Please note that it is the author(s) responsibility to obtain permission from the copyright holder to reproduce figures (or tables) that have previously been published elsewhere.

Title page

• Article title. Provides a distilled description of the complete article and should include information that, along with the abstract, will enable sensitive and specific electronic retrieval of the article. The article title should not exceed 15 words.
• Author information. Report one given name, the initials for other names, and the surname. Report each author's highest academic degree. For active military personnel and for reserve officers with ranks of LTC and above, report the abbreviated rank. Using superscript numbering, on a line below the authors’ names, indicate the affiliations [name(s) of the department(s) and institution(s) or organization(s)] where the work should be attributed. On a separate line, name the contact person and include full contact details.
• Disclaimers. A statement that the views expressed in the submitted article are the author's own and not an official position of the institution, funder, the IDF, or the IMA.
• Source(s) of support. These include grants, equipment, drugs, and/or other support that facilitated the conduct of the work described in the article or the writing of the article itself.
• Word count: Authors must state the word counts for both the abstract and the main text. The main text count should exclude the abstract, acknowledgments, tables, figure legends, and references. This information enables editors and reviewers to assess whether the paper's length is warranted by its content and ensures the manuscript fits within the journal's specific format and word limits.
• Number of tables and figures.  A combined total of no more than four (4) tables and figures is permitted for this manuscript type.

Main manuscript text

• Abstract. For manuscripts with abstracts, the abstract must be submitted in English, ranging from 150 to 250 words. For Original Research articles, a structured abstract is mandatory and must include the following subheadings: Background, Methods, Results, and Conclusions. For other manuscript types, the abstract should be structured as appropriate for the specific format. The abstract should be self-contained, providing a concise summary of the study’s purpose, key methodologies, main findings (including primary data and statistical significance), and principal conclusions, without the use of citations or undefined abbreviations.
   
• Introduction. Provide a concise context for the study, highlighting the nature of the problem and its clinical or scientific significance. Authors should clearly identify the gap in current knowledge or the unresolved clinical challenge that the study aims to address. State the specific research objective or the hypothesis being tested.
  To maintain focus, cite only directly pertinent references and avoid a comprehensive literature review. Do not include data, results, or conclusions from the current work within this section. The introduction should remain brief and purposeful, concluding with a clear statement of the study’s specific aim.
   
• Methods. The guiding principle of the Methods section should be clarity about how and why a study was done in a particular way. The Methods section should aim to be sufficiently detailed to ensure full reproducibility by other researchers. This section must be limited to information available at the time the study protocol was drafted; all data collected during the study should be presented in the Results section. The Methods section should include a statement indicating that the research was approved by an independent local, regional, or national review body (e.g., ethics committee or institutional review board).
   
• Selection and Description of Participants: Authors must clearly describe the selection of participants, including healthy individuals, patients, and control groups, and explain the rationale for each group. The manuscript should specify eligibility and exclusion criteria and provide a detailed description of the source population. As the relevance of variables such as age, sex, or ethnicity may not be fully known during the study design, researchers should strive to include representative populations and, at a minimum, provide descriptive data for all relevant demographic variables.
  Ensure correct use of the terms sex (when reporting biological factors) and gender (identity, psychosocial or cultural factors), and, unless inappropriate, report the sex and/or gender of study participants. If the study was done involving an exclusive population, for example, in only one sex, authors should justify why, except in obvious cases (e.g., prostate cancer).” Authors should define how they determined race or ethnicity and justify their relevance. Authors should use neutral, precise, and respectful language to describe study participants and avoid the use of terminology that might stigmatize participants.
   
• Technical Information: Specify the study's main and secondary objectives–usually identified as primary and secondary outcomes. Identify methods, equipment (give the manufacturer's name and address in parentheses), and procedures in sufficient detail to ensure reproducibility. For established methods, provide appropriate references; for methods that are published but not widely known, provide both references and brief descriptions. New or substantially modified methods must be described in detail, including the rationale for their use and an evaluation of their limitations.
  Identify precisely all drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration. Identify appropriate scientific names and gene names.
   
• Statistics: Describe statistical methods with enough detail to enable a knowledgeable reader with access to the original data to judge its appropriateness for the study and to verify the reported results. When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Avoid relying solely on statistical hypothesis testing, such as P values, which fail to convey important information about effect size and precision of estimates. A statement that "no significant difference was found" is only permissible if a power analysis was conducted and reported, including all relevant parameters (alpha, beta, and the expected effect size). In the absence of a formal power study, authors must instead state: "With the numbers available, no significant difference could be detected." All statistical software used must be identified by name and version.
  Authors are encouraged to use 95% confidence intervals (95% {CI}) in addition to, or instead of, standard deviations when reporting results. Specifically, 95% confidence intervals are mandatory whenever the results of survivorship analysis are presented in the text or in graphs.
  The use of the word "correlation" strictly requires the reporting of the Pearson product-moment correlation coefficient (r).
   
• Results: should be presented in a logical sequence within the text, tables, and figures, giving priority to the main or most important findings. To maintain clarity and flow, authors must avoid repeating data from tables or figures in the text, using the narrative instead to emphasize or summarize only the most significant observations. It is mandatory to provide data on all primary and secondary outcomes identified in the Methods section; any extra materials or extensive technical details should be submitted as supplementary files. Numeric results must be reported not only as derivatives (e.g., percentages) but also as the absolute numbers from which they were calculated. Tables and figures should be restricted to those essential for explaining the study's argument, and graphs should be used as an alternative to tables with numerous entries to avoid duplication. Furthermore, reporting data stratified by demographic variables, such as age and sex, should be routine to facilitate the pooling of data for subgroups across studies, and any failure to do so must be supported by a compelling justification.
   
• Discussion: The Discussion should begin with a summary of the study's main findings, followed by an exploration of possible mechanisms or explanations for these results. Authors should emphasize the novel and significant aspects of their work, placing the findings in the context of existing literature and current medical knowledge. It is essential to explicitly state the limitations of the study and discuss the implications of the findings for future research, clinical practice, or policy. Conclusions must be directly linked to the study’s original goals; however, authors must avoid unqualified statements or conclusions that are not adequately supported by the data. Specifically, a clear distinction must be made between statistical significance and clinical significance. Statements regarding economic benefits or costs should be avoided unless the manuscript includes formal economic data and analysis. Furthermore, authors should refrain from claiming priority or alluding to incomplete work that has not yet been peer-reviewed or published.

References:
References must be listed numerically in the order of their appearance in the text, rather than alphabetically. The number of references is strictly limited based on the article type: 20 for original research, 40 for review articles, 30 for clinical guidelines, 5 for case reports, and 3 for letters to the Editor. Only published articles, clinical trial registration records, and abstracts that are in press or available through public preprint servers may be cited. Unpublished data, abstracts, or personal communications should not be included in the reference list; if necessary, they may be mentioned within the text as "unpublished observations" or "personal communications" with the names of the involved researchers, provided the author has obtained explicit permission from the cited colleagues.
For citation formatting, list all authors if there are four or fewer; for five or more authors, list the first three followed by “et al.” Use the author’s surname followed by initials without punctuation (e.g., Smith AB). Journal titles should be abbreviated according to Index Medicus/MEDLINE standards, followed by the year of publication; volume(issue): page numbers (e.g., J Mil Med 2024; 10(2): 120-128.). Only footnotes are permitted as additional explanatory notes.

Examples:

1. Martin JW, Christopher GW, Eitzen EM. History of biological weapons: From poisoned darts to intentional epidemics. In: Dembek ZF, ed. Medical aspects of biological warfare. Washington, DC: Office of the Surgeon General, US Army Medical Department Center and School; Borden Institute, Walter Reed Army Medical Center; 2007:1-20.
2. Perkins MW, Pierre Z, Rezk P et al. Acute respiratory toxicity following inhalation exposure to soman in guinea pigs. Toxicol Appl Pharmacol 2010; 245(2):171-178.
3. Wright BS, Rezk PE, Graham JR et al. Acute lung Injury following Inhalation exposure to nerve agent VX in guinea pigs. Inhal Toxicol 2006; 18(6):448-437.
4. עדיני ב', לאור ד', כהן ר' וחב'. חמשת הדיברות להיערכות מערכת הבריאות בישראל לשעת חירום. הרפואה 2010; כרך 147(7):445-450.

Any in-press articles cited within the references and necessary for the reviewers' assessment of the manuscript should be made available if requested by the editorial office.
If you used a reference manager such as Endnote® or Mendeley®, do not submit in the reference manager format but extract to unformatted text.

Supplementary files
To maintain a concise manuscript while ensuring full transparency, authors are encouraged to provide supplementary materials such as additional text, anonymized datasets, tables, or multimedia files. These materials must be deposited in recognized, public repositories that guarantee data persistence for at least 10 years without modification. Data must be uploaded before submission, with the corresponding URL included in the manuscript to allow for reviewer assessment; the JIMM will publish this URL alongside the article. Importantly, results that would otherwise be described as "data not shown" must be included as supplementary files or deposited in a repository. To prevent broken links, the JIMM does not permit linking to personal or departmental websites. Each supplementary file must be cited in sequence within the main text, and individual participant details must be strictly excluded to maintain anonymity. The maximum file size for each additional file is 10 MB.
Authors must list all supplementary materials in a separate section before the References as shown below:

1. File name (e.g., Additional file 1).
2. File format including the correct file extension, for example, .pdf, .xls, .txt, .pptx (including name and a URL of an appropriate viewer if format is unusual).
3. Title of data.
4. Description of data.

Administrative documents, such as patient consent forms, language editing certificates, or tracked-changes versions of the manuscript, should not be uploaded as supplementary files.

System details:
Journal of Israeli Military Medicine (JIMM)
Katznelson Street No. 1, Kiryat Ono, Zip Code 5529801
Phone: 0723398272
Email Address: [email protected]
Website URL: https://www.ima.org.il/MedicineArmy/Default.aspx